Vault-13

ENTERA BIO LTD ENTX

SHS · Common Stock · CUSIP M40527109

11 institutional holders -2 vs Q1 2022
4,916,9704.9m shares reported held*
17.1% of all shares outstanding*
$6.5mreported value*
0 new 1 added 4 reduced 2 sold out net sold ≈ $44.3k (-33.2k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 28.8m as of 2022-06-30, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.33. Options: 5 managers hold calls ($249.0k notional), 1 hold puts ($0).

Trends to Q2 2022

Institutional holders

Managers reporting a position, each quarter

051015Q4 19: 4Q1 20: 4Q2 20: 6Q3 20: 6Q4 20: 6Q1 21: 9Q2 21: 15Q3 21: 15Q4 21: 13Q1 22: 13Q2 22: 1111Q4 19Q2 20Q4 20Q2 21Q4 21Q2 22
Numbers
QuarterHolders
Q4 20194
Q1 20204
Q2 20206
Q3 20206
Q4 20206
Q1 20219
Q2 202115
Q3 202115
Q4 202113
Q1 202213
Q2 202211

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q3 20: 2 bought or addedQ3 20: 3 cut or sold outQ4 20: 2 bought or addedQ4 20: 3 cut or sold outQ4 20Q1 21: 7 bought or addedQ1 21: 2 cut or sold outQ2 21: 10 bought or addedQ2 21: 7 cut or sold outQ2 21Q3 21: 7 bought or addedQ3 21: 8 cut or sold outQ4 21: 4 bought or addedQ4 21: 8 cut or sold outQ4 21Q1 22: 4 bought or addedQ1 22: 8 cut or sold outQ2 22: 1 bought or addedQ2 22: 6 cut or sold outQ2 22
Numbers
QuarterBought or addedCut or sold out
Q3 202023
Q4 202023
Q1 202172
Q2 2021107
Q3 202178
Q4 202148
Q1 202248
Q2 202216

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$500k$1m$1.5mQ3 21 calls: $1.2mQ3 21 puts: $628.0kQ3 21P/C 0.51Q4 21 calls: $936.0kQ4 21 puts: $267.0kQ4 21P/C 0.29Q1 22 calls: $550.0kQ1 22 puts: $0Q1 22P/C 0.00Q2 22 calls: $249.0kQ2 22 puts: $0Q2 22P/C 0.00
Numbers
QuarterCallsPutsP/C
Q3 2021$1.2m$628.0k0.51
Q4 2021$936.0k$267.0k0.29
Q1 2022$550.0k$00.00
Q2 2022$249.0k$00.00

Biggest buyers

UBS Group AG Added +2,744+2.7k

Biggest sellers

MILLENNIUM MANAGEMENT LLC Reduced -29,344-29.3k
CITADEL ADVISORS LLC Reduced -2,400-2.4k
MORGAN STANLEY Reduced -2,190-2.2k
ARK Investment Management LLC Sold out -1,744-1.7k
SIMPLEX TRADING, LLC Sold out -230-230
ROYAL BANK OF CANADA Reduced -5-5

Biggest calls

CITADEL ADVISORS LLC Reduced $132.0k99.3k shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced $71.0k53.6k shares
GROUP ONE TRADING LLC Reduced $45.0k33.8k shares
SIMPLEX TRADING, LLC Reduced $1.0k1.4k shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares

Biggest puts

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
BIOTECHNOLOGY VALUE FUND L P 13D · may seek influence new · filed 2026-08-04
Stated purposeThe Reporting Persons purchased the securities reported owned herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. April Securities Purchase Agreement and Registration Rights Agreement On April 1, 2026, … Full filing
10.0% new 17.2m≈ $30.5m 2026-08-04
OPKO HEALTH, INC. 13G · passive investor new · filed 2025-04-02 8.1% new 3.7m≈ $6.5m 2025-04-02
TCG Crossover GP III, LLC 13G · passive investor new · filed 2026-08-04 7.1% new 12.3m≈ $21.7m 2026-08-04
Vivo Opportunity Fund Holdings, L.P. 13G · passive investor new · filed 2026-08-04 6.9% new 11.8m≈ $20.9m 2026-08-04

Fell to 5% or below in the last year: Longitude Capital Partners V, LLC (4.6%, 2026-08-04), Seven Fleet Capital Management LP (4.1%, 2026-08-04)

Insider purchases and sales in Q2 2022

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
10010Q3 20: 0 buyingQ3 20: 0 sellingQ4 20: 0 buyingQ4 20: 0 sellingQ4 20Q1 21: 0 buyingQ1 21: 0 sellingQ2 21: 0 buyingQ2 21: 0 sellingQ2 21Q3 21: 0 buyingQ3 21: 0 sellingQ4 21: 0 buyingQ4 21: 0 sellingQ4 21Q1 22: 9 buyingQ1 22: 0 sellingQ2 22: 0 buyingQ2 22: 0 sellingQ2 22
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20200—0——
Q4 20200—0——
Q1 20210—0——
Q2 20210—0——
Q3 20210—0——
Q4 20210—0——
Q1 20229$199.9k0——
Q2 20220—0——

None reported in Q2 2022.

Holders, Q2 2022

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Knoll Capital Management, LLC 1.89% of their portfolio MIAMI, FL 2,484,2752.5m $3.3m $3.3m 1.89% Unchanged
2 RA CAPITAL MANAGEMENT, L.P. 0.08% of their portfolio BOSTON, MA 2,353,0002.4m $3.1m $3.1m 0.08% Unchanged
3 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 17,59717.6k $23.0k $23.0k 0.00% Unchanged
4 MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio NEW YORK, NY 16,86516.9k $22.0k $22.0k 0.00% Reduced -29.3k -29,344
5 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 12,65712.7k $17.0k $17.0k 0.00% Reduced -2.4k -2,400
6 Altium Wealth Management LLC 0.00% of their portfolio PURCHASE, NY 11,83011.8k $16.0k $16.0k 0.00% Unchanged
7 PNC Financial Services Group, Inc. 0.00% of their portfolio Pittsburgh, PA 10,00010.0k $13.0k $13.0k 0.00% Unchanged
8 UBS Group AG 0.00% of their portfolio ZURICH, V8 7,4047.4k $10.0k $10.0k 0.00% Added +2.7k +2,744
9 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 2,7662.8k $4.0k $4.0k 0.00% Reduced -2.2k -2,190
10 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 576576 $1.0k $1.0k 0.00% Reduced -5 -5
11 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged